Charles A. Rowland Jr - May 16, 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
May 16, 2023
Transactions value $
-$956,800
Form type
4
Date filed
5/18/2023, 06:31 PM
Previous filing
Jan 4, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $43.2K +40K +133.33% $1.08* 70K May 16, 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1M -40K -57.14% $25.00 30K May 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -40K -100% $0.00* 0 May 16, 2023 Common Stock 40K $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.